The Cannigma

JUNE 15, 2021

In testimony before the Senate in 2019, then-FDA Deputy Commissioner Dr. Amy Abernethy clarified that CBD products may not be marketed as food or food supplements. But the main issue with hemp derived products and their safety is less about the CBD and more about everything else in them. Shutterstock). Kevin McGovern/Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JUNE 11, 2019

June 6 2019. Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. While marijuana oil for sleep had been recommended, Hollyer had experienced some side effects after only a couple of months of use.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Project CBD

FEBRUARY 28, 2023

Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7 Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. million on these products.

CBD 144

CBD Seed-To-Sale Food Access 144

The Cannigma

JANUARY 13, 2023

The ECS touches on nearly every biological function you have, including sleep, pain, appetite, body temperature, immune function, memory, and hormone regulation. A 2019 retrospective review of 316 patients found that medical cannabis improved the experience of 88.3% Ethan Russo details the historical use of cannabis for migraines.

Terpenes 132

Terpenes Strains THC Treatment 132

Peninsula Alternative Health

MAY 15, 2019

Cannabis oil is being used successfully in combination with chemotherapy and radiation to kill cancer but also to help unwanted side effects such as nausea, loss of appetite, sleep disturbances, depression, anxiety, and pain. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

NOVEMBER 13, 2019

Pharma-grade cannabis is scarce in the world and Denmark has quickly stepped in to fill the niche, cultivating to EU GACP standards, adhering to patient safety, retailing in pharmacies, tracking every medical cannabis prescription, and making patient access affordable. The roadmap ahead includes clinical trials and more research in Denmark.

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ).

Research and Development 52

Research and Development Medicine Access Media 52

Peninsula Alternative Health

MAY 15, 2019

Cannabis oil is being used successfully in combination with chemotherapy and radiation to kill cancer but also to help unwanted side effects such as nausea, loss of appetite, sleep disturbances, depression, anxiety, and pain. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. In 2019, boxing legend, Mike Tyson, smoked a drug derived from toad venom (5-MeO-DMT). Rick Doblin, Ph.D, in/rickdoblin/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51